Biogen Inc. buy UBS Group AG
Start price
08.11.23
/
50%
€216.40
Target price
08.11.24
€291.35
Performance (%)
-25.00%
End price
09.11.24
€162.30
Summary
This prediction ended on 09.11.24 with a price of €162.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.00%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -3.027% | -3.027% | 29.575% |
| iShares Core DAX® | 1.604% | -7.448% | 3.039% |
| iShares Nasdaq 100 | -0.734% | -1.864% | 15.425% |
| iShares Nikkei 225® | 1.296% | -6.795% | 34.306% |
| iShares S&P 500 | -0.394% | -2.336% | 9.907% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $327.00 to $312.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten